Sei Investments CO Genmab A/S Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Genmab A/S stock. As of the latest transaction made, Sei Investments CO holds 37,177 shares of GMAB stock, worth $765,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,177

Previous 35,845 3.72%

Holding current value

$765,474

Previous $900,000 0.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.84 - $28.48 $31,754 - $37,935	1,332 Added 3.72%	37,177 $906,000
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $7,639 - $9,202	-304 Reduced 0.84%	35,845 $900,000
Q1 2024 May 07, 2024	SELL	$26.43 - $32.77 $81,245 - $100,734	-3,074 Reduced 7.84%	36,149 $1.08 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $1.93 Million - $2.44 Million	-68,954 Reduced 63.74%	39,223 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $43,523 - $52,124	1,234 Added 1.15%	108,177 $3.82 Million
Q2 2023 Aug 11, 2023	SELL	$37.4 - $42.94 $151,582 - $174,035	-4,053 Reduced 3.65%	106,943 $4.06 Million
Q1 2023 May 12, 2023	BUY	$34.88 - $43.22 $483,541 - $599,158	13,863 Added 14.27%	110,996 $4.19 Million
Q4 2022 Feb 10, 2023	BUY	$33.8 - $47.06 $386,333 - $537,895	11,430 Added 13.34%	97,133 $4.12 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $410,957 - $4.87 Million	13,038 Added 17.94%	85,703 $2.75 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $13,468 - $19,362	-502 Reduced 0.69%	72,665 $2.34 Million
Q1 2022 May 13, 2022	BUY	$30.95 - $39.68 $88,547 - $113,524	2,861 Added 4.07%	73,167 $2.63 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $1.95 Million - $2.56 Million	54,354 Added 340.73%	70,306 $2.77 Million
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $10.6 Million - $12.4 Million	-255,112 Reduced 94.12%	15,952 $699,000
Q2 2021 Aug 06, 2021	BUY	$32.88 - $44.57 $3.41 Million - $4.62 Million	103,694 Added 61.95%	271,064 $11.1 Million
Q1 2021 May 12, 2021	BUY	$30.92 - $44.4 $1.43 Million - $2.05 Million	46,191 Added 38.12%	167,370 $5.5 Million
Q4 2020 Feb 08, 2021	BUY	$33.66 - $40.76 $2.08 Million - $2.51 Million	61,688 Added 103.69%	121,179 $4.93 Million
Q3 2020 Dec 04, 2020	SELL	$33.07 - $38.68 $65,015 - $76,044	-1,966 Reduced 3.2%	59,491 $2.18 Million
Q3 2020 Nov 06, 2020	BUY	$33.07 - $38.68 $274,778 - $321,392	8,309 Added 15.63%	61,457 $2.25 Million
Q2 2020 Aug 17, 2020	BUY	$20.05 - $33.89 $275,146 - $465,072	13,723 Added 34.81%	53,148 $1.8 Million
Q2 2020 Aug 11, 2020	SELL	$20.05 - $33.89 $152,961 - $258,546	-7,629 Reduced 16.21%	39,425 $898,000
Q1 2020 May 14, 2020	BUY	$17.15 - $25.22 $157,196 - $231,166	9,166 Added 24.19%	47,054 $997,000
Q4 2019 Feb 06, 2020	BUY	$18.88 - $24.14 $715,325 - $914,616	37,888 New	37,888 $846,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Genmab A/S Transaction History